Effects of the PARP Inhibitor Olaparib on the Response of Human Peripheral Blood Leukocytes to Bacterial Challenge or Oxidative StressSidnéia Sousa Santos, Reinaldo Salomão|Biomolecules|2022Cited by 23
A randomized, double-blind, placebo-controlled trial of IL-7 in critically ill patients with COVID-19Manu Shankar‐Hari, Richard S. Hotchkiss, Kenneth E. Remy et al.|JCI Insight|2025Cited by 21
Evaluation of Toll-like, chemokine, and integrin receptors on monocytes and neutrophils from peripheral blood of septic patients and their correlation with clinical outcomesStein Silva, Reinaldo Salomão|Brazilian Journal of Medical and Biological Research|2014Cited by 17